Schedule 13G ownership disclosure
Greenwich Lifesciences Inc
Security class unavailable · CUSIP: 396879108
Event date: 2021-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,304,681
- Percent of class
- 17.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-22-017454
- Form type
- SC 13G
- Filer
- Greenwich LifeSciences, Inc.
- CIK
- CIK 1799788
- Filed
- Jun 22, 2022
- Reporting period
- Dec 29, 2021
- Description
- Schedule 13G beneficial ownership